• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

S1P molecule regulates dendritic cell localization and vascular integrity in lymph nodes

Bioengineer by Bioengineer
October 2, 2019
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Image by Dr. Szandor Simmons, Osaka University

The trafficking of white blood cells called lymphocytes is crucial for controlling our immune response. Maintaining the integrity of high endothelial venules (HEVs) — the gateway for lymphocytes to move from the blood into lymph nodes (LNs) — is therefore crucial. This study describes for the first time how a molecule called sphingosine-1-phosphate (S1P) positively influences the function and integrity of HEVs. It also reveals how the activation of sphingosine-1-phosphate receptor-1 (S1PR1) signalling influences HEV interactions with dendritic cells (cells that carry messages between the innate and adaptive immune systems). The researchers hope this work will inspire future research to better understand how endothelial cells (the cells that line the interior surface of blood vessels and lymphatic vessels) distinguish S1P-signalling from the signals generated by high levels of S1P in the blood, thereby ensuring the proper maintenance of our immunity and tolerance. Greater understanding of these processes could have implications for studying orchestration of anti-cancer immunity and autoimmune diseases such as rheumatoid arthritis.

Interview to Dr. Szandor Simmons

What question did you set out to answer in your study?

We intended to describe the influence of sphingosine-1-phosphate, a bioactive sphingolipid mediator, on the function and integrity of high-endothelial venules (HEVs), which are specialized postcapillary venules that facilitate lymphocyte immigration from peripheral blood circulation into e.g. lymph nodes.

Can you briefly summarize the key findings of your paper?

We found that HEVs, which were deficient for the S1P-transporter Spinster-homologue-2, were unable to attract dendritic cells in order to trigger LTβr-signaling through cell-cell contact with HEVs. We observed a comparable phenotype when HEVs were unable to signal through S1P-receptor-1. Therefore, CCL21 release from HEVs was reduced and DC-HEV interactions abrogated, which led to impairment of HEVs, reduced lymphocyte immigration into the lymph node parenchyma, and to the development of hypotrophic lymph nodes.

What is the impact of your work? How/why are your findings important for other scientists, and what could they mean for the everyday reader?

Lymphocyte trafficking is crucial for controlling adaptive immune responses. Hence, the maintenance of the integrity of high endothelial venules (HEVs), the gateway of lymphocytes from the blood into the lymph nodes (LNs), is a key issue. To our knowledge, so far, no studies have described the influence of sphingosine-1-phosphate on the function and integrity of HEVs. Furthermore, we describe how the autocrine activation of sphingosine-1-phosphate receptor-1 (S1PR1) signaling influences HEV and dendritic cell (DC) interactions. Our work provides an explanation for the well documented organization of dendritic cells in the lymph node and hopefully will inspire future work to better understand how endothelial cells distinguish the autocrine S1P-signaling from signals generated by high levels of S1P in the blood. For maintenance of immunity and tolerance, the organs and tissues of the organism are connected by migrating lymphoid cells. Understanding lymphocyte migration is essential for many disorders and diseases.

###

The article “High-endothelial cell-derived S1P regulates dendritic cell localization and vascular integrity in the lymph node” was published in eLife at DOI: https://doi.org/10.7554/eLife.41239.

About Osaka University

Osaka University was founded in 1931 as one of the seven imperial universities of Japan and now has expanded to one of Japan’s leading comprehensive universities. The University has now embarked on open research revolution from a position as Japan’s most innovative university and among the most innovative institutions in the world according to Reuters 2015 Top 100 Innovative Universities and the Nature Index Innovation 2017. The university’s ability to innovate from the stage of fundamental research through the creation of useful technology with economic impact stems from its broad disciplinary spectrum.

Website: https://resou.osaka-u.ac.jp/en/top

Media Contact
Saori Obayashi
[email protected]

Original Source

https://elifesciences.org/?gclid=EAIaIQobChMI6MLo0LT65AIVTz5gCh1hwAsWEAAYASAAEgLbTPD_BwE

Related Journal Article

http://dx.doi.org/10.7554/eLife.41239

Tags: Immunology/Allergies/AsthmaMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Stefan Kappe, Ph.D., Renowned Malaria Researcher, Named Director of UM School of Medicine’s Center for Vaccine Development and Global Health

Stefan Kappe, Ph.D., Renowned Malaria Researcher, Named Director of UM School of Medicine’s Center for Vaccine Development and Global Health

September 8, 2025

TriCAM Study Explores Complementary Medicine in Stem Cell Transplants

September 8, 2025

PRMT1 Protein Mitigates Brain Damage After Ischemia by Inhibiting RIPK1-Driven Cell Death Pathways

September 8, 2025

New C-3-Substituted Oleanolic Acid Benzyl Amide Shows Promise Against Influenza A by Inhibiting PA–PB1 Interaction and Regulating Macrophage Inflammation

September 8, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New Open-Source Data Platform Launched to Advance Lung Cancer Genetics Research

AI Reveals Stress Levels in Farmed Amazonian Fish, New Study Shows

Overcoming Resistance Mutations and the Blood–Brain Barrier: Major Challenges in Targeted Therapy for Brain Metastases in Non-Small Cell Lung Cancer

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.